64578-0150 NDC - ADRENAL-TONE (ADRENALINUM, AVENA, GINKGO, GLYCYRRHIZA, KALI PHOS, NAT MUR, NUX VOMICA, PHOSPHORICUM AC, PITUITARUM POSTERIUM, SARSAPARILLA, THYROIDINUM, VERATRUM ALB, ZINC MET.)

Drug Information

Product NDC: 64578-0150

Proprietary Name: Adrenal-Tone

Non Proprietary Name: Adrenalinum, Avena, Ginkgo, Glycyrrhiza, Kali phos, Nat mur, Nux vomica, Phosphoricum ac, Pituitarum posterium, Sarsaparilla, Thyroidinum, Veratrum alb, Zinc met.

Active Ingredient(s):
  • 4 [hp_X]/59.1mL AVENA SATIVA FLOWERING TOP;
  • 12 [hp_X]/59.1mL EPINEPHRINE;
  • 4 [hp_X]/59.1mL GINKGO;
  • 4 [hp_X]/59.1mL GLYCYRRHIZA GLABRA;
  • 12 [hp_X]/59.1mL PHOSPHORIC ACID;
  • 12 [hp_X]/59.1mL POTASSIUM PHOSPHATE, DIBASIC;
  • 4 [hp_X]/59.1mL SARSAPARILLA;
  • 12 [hp_X]/59.1mL SODIUM CHLORIDE;
  • 12 [hp_X]/59.1mL STRYCHNOS NUX-VOMICA SEED;
  • 12 [hp_X]/59.1mL SUS SCROFA PITUITARY GLAND, POSTERIOR;
  • 6 [hp_X]/59.1mL THYROID, UNSPECIFIED;
  • 12 [hp_X]/59.1mL VERATRUM ALBUM ROOT;
  • 12 [hp_X]/59.1mL ZINC


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Adrenergic alpha-Agonists [MoA];
  • Adrenergic beta-Agonists [MoA];
  • Allergens [CS];
  • Allergens [CS];
  • Catecholamine [EPC];
  • Catecholamines [CS];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Dietary Proteins [CS];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased IgG Production [PE];
  • Increased Large Intestinal Motility [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Non-Standardized Food Allergenic Extract [EPC];
  • Non-Standardized Plant Allergenic Extract [EPC];
  • Non-Standardized Plant Allergenic Extract [EPC];
  • Osmotic Activity [MoA];
  • Osmotic Laxative [EPC];
  • Plant Proteins [CS];
  • Plant Proteins [CS];
  • Seed Storage Proteins [CS];
  • alpha-Adrenergic Agonist [EPC];
  • beta-Adrenergic Agonist [EPC]

Labeler Information

Labeler Name: Energetix Corporation
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:11/3/2017

Package Information

No. Package Code Package Description Billing Unit
164578-0150-159.1 mL in 1 BOTTLE, DROPPER (64578-0150-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC64578-0150The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEAdrenal-ToneThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAdrenalinum, Avena, Ginkgo, Glycyrrhiza, Kali phos, Nat mur, Nux vomica, Phosphoricum ac, Pituitarum posterium, Sarsaparilla, Thyroidinum, Veratrum alb, Zinc met.The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE11/3/2017This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEEnergetix CorporationName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEAVENA SATIVA FLOWERING TOP; EPINEPHRINE; GINKGO; GLYCYRRHIZA GLABRA; PHOSPHORIC ACID; POTASSIUM PHOSPHATE, DIBASIC; SARSAPARILLA; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA PITUITARY GLAND, POSTERIOR; THYROID, UNSPECIFIED; VERATRUM ALBUM ROOT; ZINCAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH4; 12; 4; 4; 12; 12; 4; 12; 12; 12; 6; 12; 12 
ACTIVE INGRED UNIT[hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL 
PHARM CLASSESAdrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023